Ultraviolet therapy of HIV-infected individuals: a panel discussion.
Patients infected with the human immunodeficiency virus (HIV) frequently develop skin diseases that are responsive to ultraviolet (UV) radiation. Studies on the effects of UV on HIV and on the immune system in vitro and in transgenic animals have raised questions regarding the safety of UV exposure in these patients. In this article, invited experts address issues concerning the safety of ultraviolet therapy in HIV-infected patients by discussing their clinical and/or research experience.
Houpt
K R
KR
Department of Dermatology, The University of Texas Southwestern Medical Center, Dallas 75235-9069, USA.
Beer
J Z
JZ
Horn
T D
TD
Moy
J A
JA
Zmudzka
B Z
BZ
Cruz
P D
PD
D000818:Animals; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D006801:Humans; D011701:PUVA Therapy; D012871:Skin Diseases / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D016896:Treatment Outcome; D014467:Ultraviolet Therapy